License Agreement Expands Zomedica's Portfolio with Revolutionary Hemostatic Technology ANN ARBOR, MI / ACCESSWIRE / January ...

Indian Hemostat IndustryThe Indian hemostat market, valued at USD 54.1 million in 2015, is expected to experience steady growth, expanding at a compound annual growth rate (CAGR) of 5.8% between 2016 ...

Demonstrated to stop bleeding faster than competitive hemostatic agents. "We are excited to add Vetigel® to Zomedica's portfolio of innovative veterinary products," said Kevin Klass, Senior Vice ...

Cell Therapy and Tissue Engineering Group (TERCIT), Research Institute on Health Sciences (IUNICS), University of the Balearic Islands (UIB), 07122 Palma, Mallorca, Spain Health Research Institute of ...

License Agreement Expands Zomedica's Portfolio with Revolutionary Hemostatic Technology ANN ARBOR, MI / ACCESSWIRE / January 7, 2025 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), ...

One theme that stood out was the rise of AI Agents. In this context, the sense of “agent” is the difference between using a tool to accomplish something yourself and asking someone to do ...

"This partnership with Zomedica is ideal for the future of Vetigel," said Joe Landolina, CEO of Cresilon, in the ...

Three methods frequently used to achieve hemostasis during or at the end of a surgical procedure are simple direct pressure, hemostatic agents, and electrocautery. Numerous methods and formats for ...